Niall Antony Armes

Sapphiros is a privately held consumer diagnostics platform company that invests in growth-stage diagnostic companies. Sapphiros is based in Boston, MA and has subsidiaries in the United Kingdom. The company aims to bridge the gap between present and future by focusing on innovative, patient-centric technologies. Sapphiros' portfolio of capabilities and technologies includes novel sample collection, next generation diagnostics, computational biology, and printed electronics, which help consumers access important diagnostic results quickly. The company empowers exceptional entrepreneurs with the full strength of the platform's resources, capital, and expertise to accelerate and enhance growth and impact. The company was founded by Niall Antony Armes and Namal Nawana. Mark Gladwell has been the CEO of the company since 2021.

Part of Sapphiros, BioCrucible Ltd. is a British company that develops high-performance molecular consumer diagnostics. The company is based in Cambridge, UK. BioCrucible is developing next-generation diagnostics based upon breakthrough advances in biomolecular condensate formation. The company aims to develop proprietary molecular detection technologies deploying ultra-rapid isothermal nucleic acid amplification that enable near-patient and at-home testing for infectious disease or genetic indications. The company was founded in 2018 by Niall Antony Armes. Per Grufman has been the CEO of the company since January 20, 2023. BioCrucible was acquired by Sapphiros on July 21, 2021.

Sapphiros is a privately held consumer diagnostics platform company that invests in growth-stage diagnostic companies. Sapphiros is based in Boston, MA and has subsidiaries in the United Kingdom. The company aims to bridge the gap between present and future by focusing on innovative, patient-centric technologies. Sapphiros' portfolio of capabilities and technologies includes novel sample collection, next generation diagnostics, computational biology, and printed electronics, which help consumers access important diagnostic results quickly. The company empowers exceptional entrepreneurs with the full strength of the platform's resources, capital, and expertise to accelerate and enhance growth and impact. The company was founded by Niall Antony Armes and Namal Nawana. Mark Gladwell has been the CEO of the company since 2021.

Sapphiros is a privately held consumer diagnostics platform company that invests in growth-stage diagnostic companies. Sapphiros is based in Boston, MA and has subsidiaries in the United Kingdom. The company aims to bridge the gap between present and future by focusing on innovative, patient-centric technologies. Sapphiros' portfolio of capabilities and technologies includes novel sample collection, next generation diagnostics, computational biology, and printed electronics, which help consumers access important diagnostic results quickly. The company empowers exceptional entrepreneurs with the full strength of the platform's resources, capital, and expertise to accelerate and enhance growth and impact. The company was founded by Niall Antony Armes and Namal Nawana. Mark Gladwell has been the CEO of the company since 2021.

Part of Sapphiros, BioCrucible Ltd. is a British company that develops high-performance molecular consumer diagnostics. The company is based in Cambridge, UK. BioCrucible is developing next-generation diagnostics based upon breakthrough advances in biomolecular condensate formation. The company aims to develop proprietary molecular detection technologies deploying ultra-rapid isothermal nucleic acid amplification that enable near-patient and at-home testing for infectious disease or genetic indications. The company was founded in 2018 by Niall Antony Armes. Per Grufman has been the CEO of the company since January 20, 2023. BioCrucible was acquired by Sapphiros on July 21, 2021.

Sapphiros is a privately held consumer diagnostics platform company that invests in growth-stage diagnostic companies. Sapphiros is based in Boston, MA and has subsidiaries in the United Kingdom. The company aims to bridge the gap between present and future by focusing on innovative, patient-centric technologies. Sapphiros' portfolio of capabilities and technologies includes novel sample collection, next generation diagnostics, computational biology, and printed electronics, which help consumers access important diagnostic results quickly. The company empowers exceptional entrepreneurs with the full strength of the platform's resources, capital, and expertise to accelerate and enhance growth and impact. The company was founded by Niall Antony Armes and Namal Nawana. Mark Gladwell has been the CEO of the company since 2021.

Sapphiros is a privately held consumer diagnostics platform company that invests in growth-stage diagnostic companies. Sapphiros is based in Boston, MA and has subsidiaries in the United Kingdom. The company aims to bridge the gap between present and future by focusing on innovative, patient-centric technologies. Sapphiros' portfolio of capabilities and technologies includes novel sample collection, next generation diagnostics, computational biology, and printed electronics, which help consumers access important diagnostic results quickly. The company empowers exceptional entrepreneurs with the full strength of the platform's resources, capital, and expertise to accelerate and enhance growth and impact. The company was founded by Niall Antony Armes and Namal Nawana. Mark Gladwell has been the CEO of the company since 2021.